With Japanese companies apparently willing to pay up for American growth and market share, who else should investors consider as potential take-out plays?
Given Imaging (GIVN)
Imaging is one of the relatively few areas where Japanese healthcare companies have established a global presence. Although Given Imaging's swallowed camera capsule systems are a considerably different animal, the higher incidence of GI disorders in Japan would make it a logical fit. The company already has a distribution agreement with Fujifilm for Japan, and Olympus has attempted to enter this market as well, so it is not as though this is a completely unfamiliar product or company to the Japanese market.
Although the Given PillCam approach doesn't lend itself to biopsies, it's a more comfortable diagnostic for patients. With the company looking to launch a product targeted at the colonoscopy market, Given's PillCam could be a solid growth product for many years. Although Given Imaging derives much of its revenue from the U.S., it is headquartered in Israel.